I will never discount the "government corruption" angle, but I have to admit that I became very concerned when I heard the file was 1200 pages thick. Then I learned that it included all of the previous review team's questions & it was in such an incoherent format that Dean decided to send a new one replete with annotations. I believe the FDA had sufficient grounds to reject the application if it truly was a "mess" & missing financials.
I hope the consultants will clean it up & fill in all the blanks. At that point the FDA should have no problem granting SE. Until then, as sad as it is for my stock account, I have to agree with the decision.